0000899243-17-002273.txt : 20170131 0000899243-17-002273.hdr.sgml : 20170131 20170131160535 ACCESSION NUMBER: 0000899243-17-002273 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170130 FILED AS OF DATE: 20170131 DATE AS OF CHANGE: 20170131 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: KERYX BIOPHARMACEUTICALS INC CENTRAL INDEX KEY: 0001114220 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 134087132 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 617-466-3500 MAIL ADDRESS: STREET 1: ONE MARINA PARK DR. CITY: BOSTON STATE: MA ZIP: 02210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Madison Greg CENTRAL INDEX KEY: 0001564955 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-30929 FILM NUMBER: 17561171 MAIL ADDRESS: STREET 1: ONE MARINA PARK DRIVE CITY: LEXINGTON STATE: MA ZIP: 02210 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2017-01-30 0 0001114220 KERYX BIOPHARMACEUTICALS INC KERX 0001564955 Madison Greg C/O KERYX BIOPHARMACEUTICALS, INC. ONE MARINA PARK DRIVE, 12TH FLOOR BOSTON MA 02210 1 1 0 0 President and CEO Common Stock 2017-01-30 4 S 0 18248 4.65 D 235322 D Sale of a total of 18,248 shares of common stock was made in order to satisfy Mr. Madison's income tax withholding obligation upon the vesting of 51,251 shares of restricted stock on January 27, 2017. Mr. Madison had no discretion with respect to such sale, which was transacted automatically in accordance with the Issuer's corporate policies regarding the vesting of restricted stock. Includes 118,790 shares of restricted stock. /s/ Brian Adams, Attorney-in-Fact 2017-01-31